HP plans to explore a combination with Xerox for first time since its rival launched a $35bn hostile takeover bid, as the Palo Alto-based PC and printer maker announced an aggressive plan to return up to $16n to its shareholders in the next three years.
While the move to return about half of HP’s market capitalization to investors is a de facto poison pill to block Xerox’s takeover approach initiated last year, the company’s chief executive told the FT that a deal was possible under varied terms, including HP buying its smaller rival.
“We are willing to engage with them,” Enrique Lores, the chief executive of HP said in an interview over the phone. “It is not about who buys what, it is really about creating value.” As part of the plan announced on Monday afternoon, HP said that it would repurchase at least $8bn worth of HP shares over the next 12 months. By 2022 it planned to buy back $7bn more worth of stock and generate savings of $1.2bn.
HP’s response came as it reported quarterly earnings that were well ahead of analysts’ expectations and lifted its forecasts for the rest of the year. The capital return plan is far more aggressive than the financial goals HP outlined at an analyst meeting in October, shortly before Mr Lores became CEO.
Speaking on Monday, however, he brushed off the suggestion that it had taken Xerox’s bid to prompt HP to act, and instead said he had wanted to unveil a strong set of results to Wall Street before laying out the plan. “Our three-year financial targets reflect a company at the top of its game, combining the industry’s best innovation with disciplined cost management and aggressive capital returns to support a compelling investment in both the short and long term,” said Mr Lores.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand